Dr. Paul A. DiSilvestro
Claim this profileWomen and Infants Hospital
Studies Cancer
Studies Ovarian Cancer
8 reported clinical trials
39 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage II
2Ovarian Cancer
Stage IV
Stage III
BRCA1 positive
Affiliated Hospitals
Clinical Trials Paul A. DiSilvestro is currently running
Iohexol-aided Carboplatin Dosing
for Cancer
This trial studies how well iohexol helps doctors calculate the dose of carboplatin for cancer patients. By measuring kidney function more accurately, doctors can improve the effectiveness and safety of carboplatin treatment. Carboplatin is a platinum-based chemotherapy drug used to treat various cancers, known for its improved toxicity profile compared to cisplatin.
Recruiting1 award Phase 17 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
More about Paul A. DiSilvestro
Clinical Trial Related12 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Paul A. DiSilvestro has experience with
- Cisplatin
- Biospecimen Collection
- Olaparib
- Radiotherapy
- Behavioral Dietary Intervention
- Compliance Monitoring
Breakdown of trials Paul A. DiSilvestro has run
Cancer
Ovarian Cancer
Adenocarcinoma
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul A. DiSilvestro specialize in?
Paul A. DiSilvestro focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Paul A. DiSilvestro currently recruiting for clinical trials?
Yes, Paul A. DiSilvestro is currently recruiting for 3 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Paul A. DiSilvestro has studied deeply?
Yes, Paul A. DiSilvestro has studied treatments such as Cisplatin, Biospecimen Collection, Olaparib.
What is the best way to schedule an appointment with Paul A. DiSilvestro?
Apply for one of the trials that Paul A. DiSilvestro is conducting.
What is the office address of Paul A. DiSilvestro?
The office of Paul A. DiSilvestro is located at: Women and Infants Hospital, Providence, Rhode Island 02905 United States. This is the address for their practice at the Women and Infants Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.